PURCHASE AGREEMENT
Exhibit
4.1
THIS
PURCHASE AGREEMENT (the
"Agreement"),
dated
as
of April 19, 2007, by and among Mohen, Inc. d/b/a Spiral Frog, a Delaware
corporation (the "Company"),
and
the
investors
listed on the Schedule of Buyers attached hereto (individually, a "Buyer"
and
collectively,
the "Buyers").
WHEREAS:
A. On
dates
beginning on March 13, 2007, certain buyers of the Company’s securities
executed
written purchase agreements for the purchase thereof and now such buyers wish
to
amend
and
restate such agreements.
B. The
Company and each Buyer is executing and delivering this Agreement in reliance
upon
the
exemption from securities registration afforded by Section 4(2) of the
Securities Act of 1933, as amended (the "1933
Act"), and
Rule
506 of Regulation D ("Regulation
D") as
promulgated by the United States Securities and Exchange Commission (the
"SEC")
under
the
1933 Act.
C. The
Company has authorized a series of senior secured exchangeable notes of the
Company, which notes shall be exchangeable into the Company's Class A Common
Stock, par value $0.001 per share (the "Common
Stock"), in
accordance with the terms of the Notes (as defined below).
D. Each
Buyer wishes to purchase, and the Company wishes to sell, upon the terms and
conditions
stated in this Agreement that aggregate principal amount of the Notes, in
substantially the
form
attached hereto as Exhibit
A (the
"Notes"),
set
forth
opposite such Buyer's name in column
(3) on the Schedule of Buyers attached hereto (which aggregate amount for all
Buyers shall
be
$5,000,000 (as exchangeable into Common Stock pursuant to the terms of the
Notes, collectively, the “Exchange
Shares”).
E. Contemporaneously
with the execution and delivery of this Agreement, the parties hereto are
executing and delivering a Registration Rights Agreement, substantially in
the
form attach
hereto as Exhibit
B (the
“Registration
Rights Agreement”) pursuant
to which the Company
has agreed to provide certain registration rights with respect to the Exchange
Shares under
the
1933 Act and the rules and regulations promulgated thereunder, and applicable
state securities laws.
F. The
Notes
and the Exchange Shares collectively are referred to herein as the "Securities".
G.
The
Notes will rank senior to all future indebtedness of the Company, subject to
Permitted
Senior Indebtedness (as defined in the Notes) and will be secured by a perfected
security
interest in all of the assets of the Company and each of the Company’s
subsidiaries, as evidenced
by the security agreement attached hereto as Exhibit
C (the
"Security
Agreement" and,
together with the Pledge Agreement attached hereto as Exhibit
D, and
any
ancillary documents
related thereto, collectively the "Security
Documents").
H.
To
facilitate the Closing (as defined herein), each Buyer shall deposit into
escrow
its respective Purchase Price (as defined herein) with Gottbetter &
Partners, LLP (the “Escrow
Agent”) pursuant
to an Escrow Agreement, among the parties hereto.
NOW,
THEREFORE, the
Company and each Buyer hereby agree as follows: 1. PURCHASE
AND SALE OF NOTES.
(a) Purchase
of Notes.
(b) Subject
to the terms of this Agreement and the satisfaction (or waiver) of the
conditions
set forth in Sections 6 and 7 below, the Company shall issue and sell to each
Buyer, and
each
Buyer severally, but not jointly, shall purchase from the Company, on the
Closing Date (as
defined below), a principal amount of Notes as is set forth opposite such
Buyer's name in column (3) on the Schedule of Buyers (the "Closing").
(i) Closing.
The
Closing shall take place at 10:00 a.m., New York City time, at
the
offices of Gottbetter & Partners, LLP, 000 Xxxxxxx Xxxxxx, Xxx Xxxx, XX
00000,
or
at such other place or time as mutually agreed to by the parties, which shall
be
no
later
than the second business day after the satisfaction (or waiver) of the last
to
be satisfied (or waived) of the conditions to the Closing set forth in Sections
6 and 7 below (other
than conditions that by their terms are to be satisfied on the Closing Date).
The date
on
which the Closing actually takes place is referred to as the "Closing
Date."
(ii) Purchase
Price. The
aggregate purchase price for the Notes to be purchased
by each Buyer at the Closing or a Subsequent Closing (as defined below), as
the
case
may be, (the "Purchase
Price"), shall
be
the amount set forth opposite such Buyer's
name in column (3) of the Schedule of Buyers.
(c) Form
of Payment. On
the
Closing Date, (i) upon receipt of the Joint Written Directions
(as defined in the Escrow Agreement), the Escrow Agent shall deliver each
Buyer’s Purchase
Price to the Company or designated third parties for the Notes to be issued
and
sold to such
Buyer at the Closing by wire transfer of immediately available funds in
accordance with such
Joint Written Directions, and (ii) the Company shall deliver to each Buyer
the
Notes (in the principal
amounts as such Buyer shall have requested prior to the Closing) which such
Buyer is then
purchasing, in each case duly executed on behalf of the Company and registered
in the name
of
such Buyer or its permitted designee.
(d) Subsequent
Closing. Subject
to the terms and conditions of this Agreement, after the Closing and at any
time
on or prior to thirty (30) days following the Closing, at a subsequent
closing
(a “Subsequent
Closing”), the
Company may issue and sell to one or more individuals and
entities approved by the Company’s Board of Directors (each an “Additional
Buyer” and
collectively,
the “Additional
Buyers”) an
aggregate principal amount of Notes up to an aggregate
of $5,000,000, including all previously issued Notes, at the Purchase Price.
All
Buyers
at
previous closings shall be given the option to rescinding their purchase of
Notes and have
their money returned by the Company or to have their Notes and other purchase
documents amended
to the terms set forth herein and in the Transaction Document contemplated
hereby. At a
Subsequent Closing the representations and warranties of the Company set forth
in Section 3 hereof
shall speak as of the date of the Subsequent Closing (subject to any updates
to
the Disclosure
Schedules as may be made by the Company), and the representations and warranties
of
the
Additional Buyers shall speak as of the date of the respective Subsequent
Closing. At a Subsequent Closing, (i) each Additional Buyer and the Company
shall execute a counterpart signature
page hereto and to the relevant Transaction Documents, (ii) the Company shall
cause the
Schedule of Buyers hereto to be updated to reflect the purchases made by the
Additional Buyers,
(iii) each Additional Buyer shall become a “Buyer” hereunder and the Notes
purchased by
such
Additional Buyer shall be deemed “Notes”, for purposes of this Agreement and the
other Transaction
Documents, and (iv) subject to the terms and conditions hereof, the Company
will
deliver
to each of the Additional Buyers purchasing Notes at a Subsequent Closing the
applicable Notes
registered in the name of such Additional Buyer, against payment to the Company
of the Purchase
Price therefor in cash by wire transfer, check or other method acceptable to
the
Company.
2
2.BUYER'S
REPRESENTATIONS AND WARRANTIES.
As
a
material inducement to the Company to enter into this Agreement and sell the
Notes hereunder,
each Buyer represents and warrants to the Company with respect to only itself
as
of the
date
hereof that:
(a) No
Public Sale or Distribution. Such
Buyer is acquiring the Notes for its own account and with the present intention
of holding such securities for the purposes of investment, and
not
with a view towards, or for resale in connection with, the public sale or
distribution thereof,
except pursuant to sales registered or exempt from registration under the 1933
Act; provided,
however, that
by
making the representations herein, such Buyer does not agree to hold
any
of
the Securities for any minimum or other specific term and reserves the right
to
dispose of the
Securities at any time in accordance with or pursuant to a registration
statement or an exemption
from registration under the 1933 Act. Such Buyer does not presently have any
agreement or understanding, directly or indirectly, with any Person to
distribute any of the Securities.
(b) Accredited
Investor Status. Such
Buyer is an "accredited investor" as that term is defined
in Rule 501(a) of Regulation D under the 1933 Act. Such Buyer is not a
registered broker-dealer
under Section 15 of the 1934 Act (as defined herein) or an entity engaged in
the
business of being a broker-dealer and is acquiring the Securities hereunder
in
the ordinary course of its business.
(c)
Reliance
on Exemptions. Such
Buyer understands that the Securities are being offered
and sold to it in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the
Company is relying in part upon the truth and accuracy of, and such Buyer's
compliance with, the representations, warranties, agreements, acknowledgments
and understandings of such Buyer set forth herein in order to determine
the availability of such exemptions and the eligibility of such Buyer to acquire
the Securities.
3
(d) Information.
Such
Buyer and its advisors, if any, have been furnished with all materials relating
to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities which have been requested by such Buyer.
Such Buyer and its
advisors, if any, have been afforded the opportunity to ask questions of the
Company. Neither such
inquiries nor any other due diligence investigations conducted by such Buyer
or
its advisors,
if any, or its representatives shall modify, amend or affect such Buyer's right
to rely on the
Company's representations and warranties contained herein. Such Buyer
understands that its investment
in the Securities involves a high degree of risk. Such Buyer has sought such
accounting,
legal and tax advice as it has considered necessary to make an informed
investment decision with respect to its acquisition of the
Securities.
(e) No
Governmental Review. Such
Buyer understands that no United States federal or
state
agency or any other government or governmental agency has passed on or made
any
recommendation
or endorsement of the Securities or the fairness or suitability of the
investment in
the
Securities nor have such authorities passed upon or endorsed the merits of
the
offering of the Securities.
(f) Transfer
or Resale. Such
Buyer understands that, except as provided for in the Registration
Rights Agreement: (i) the Securities have not been and are not being registered
under
the
1933 Act or any state securities laws, and may not be offered for sale, sold,
assigned or transferred
unless (A) subsequently registered thereunder, (B) such Buyer shall have
delivered to the
Company an opinion of counsel, in a form reasonably acceptable to the Company,
to the effect
that such Securities to be sold, assigned or transferred may be sold, assigned
or transferred (1) pursuant to an exemption from such registration, or (2)
pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act, as amended
(or
any successor rule thereto); (ii) any sale of the Securities
made in reliance on Rule 144 or Rule 144A may be made only in accordance with
the terms
of
Rule 144 or Rule 144A, respectively, and further, if neither Rule 144 nor Rule
144A is applicable,
any resale of the Securities under circumstances in which the seller (or the
Person (as defined
in Section 3(o) below) through whom the sale is made) may be deemed to be an
underwriter (as that term is defined in the 0000 Xxx) may require compliance
with some other exemption
under the 1933 Act or the rules and regulations of the SEC thereunder; and
(iii)
neither
the Company nor any other Person is under any obligation to register the
Securities under the
1933
Act or any state securities laws or to comply with the terms and conditions
of
any exemption thereunder. The Securities may be pledged in connection with
a
bona fide margin account or other loan or financing arrangement secured by
the
Securities and such pledge of Securities
shall not be deemed to be a transfer, sale or assignment of the Securities
hereunder, and
no
Buyer effecting a pledge of Securities shall be required to provide the Company
with any notice thereof or otherwise make any delivery to the Company pursuant
to this Agreement or any other
Transaction Document (as defined in Section 3(b)), including, without
limitation, this Section
2(f).
(g) Legends.
Such
Buyer understands that the certificates or other instruments representing
the Notes and the stock certificates representing the Exchange Shares, except
as
set forth below, shall bear any legend as required by federal law and the "blue
sky" laws of any state and
a
restrictive legend in substantially the following form (and a stop-transfer
order may be placed
against transfer of such stock certificates):
4
NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR
THE
SECURITIES INTO WHICH THESE SECURITIES ARE EXCHANGEABLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE
OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN
THE
ABSENCE OF (I) AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (II) AN
OPINION OF COUNSEL, IN A FORM
REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER
SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR
OTHER
LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES.
The
legend set forth above shall be removed and the Company shall issue a
certificate without such
legend to the holder of the Securities upon which it is stamped, if, unless
otherwise required by
federal or state securities laws, (i) such Securities are transferred through
a
registered resale under the 1933 Act, or (ii) in connection with a sale,
assignment or other transfer, such holder provides
the Company with an opinion of counsel, in a form reasonably acceptable to
the
Company,
to the effect that (A) such sale, assignment or transfer of the Securities
may
be made without
registration under the applicable requirements of the 1933 Act, or (B) that
the
Securities can
be
sold, assigned or transferred pursuant to Rule 144.
(h) Authorization;
Enforcement; Validity. Such
Buyer has the requisite power and authority
to enter into and perform its obligations under this Agreement and each of
the
other Transaction
Documents (as defined below) to which it is a party. This Agreement and each
of
the other
Transaction Documents (as defined below) to which Buyer is a party has been
duly
and validly
authorized, executed and delivered on behalf of such Buyer, and constitute
the
legal, valid
and
binding obligations of such Buyer enforceable against such Buyer in accordance
with their
respective terms, except as such enforceability may be limited by general
principles of equity
or
to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
and other similar
laws relating to, or affecting generally, the enforcement of applicable
creditors' rights and remedies.
(i) No
Conflicts. The
execution, delivery and performance by such Buyer of this Agreement
and the other Transaction Documents to which such Buyer is a party and the
consummation by such Buyer of the transactions contemplated hereby and thereby
will not (i) result in a violation of the organizational documents of such
Buyer
or (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become
a
default)
under, or give to others any rights of termination, amendment, acceleration
or
cancellation
of, any agreement, indenture or instrument to which such Buyer is a party,
or
(iii) result
in
a violation of any law, rule, regulation, order, judgment or decree (including
federal and state
securities laws) applicable to such Buyer, except in the case of clauses (ii)
and (iii) above, for
such
conflicts, defaults, rights or violations which would not, individually or
in
the aggregate, reasonably
be expected to have a material adverse effect on the ability of such Buyer
to
perform its obligations hereunder.
5
(j) Residency.
Such
Buyer is a resident of that jurisdiction specified below its address
on the Schedule of Buyers.
(k) Independent
Investment Decision. Such
Buyer has independently evaluated the merits
of
its decision to purchase the Securities pursuant to the Transaction Documents,
and such Buyer
confirms that it has not relied on the advice of any other Buyers’ business
and/or legal counsel in making such decision.
(l) [Reserved]
(m) General
Solicitation. Such
Buyer is not purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in
any
newspaper, magazine or similar media or broadcast over television or radio
or
presented at any seminar.
(n)
Organization;
Authority. Such
Buyer is an entity duly organized, validly existing and
in
good standing under the laws of the jurisdiction of its organization with the
requisite corporate
or partnership or other entity power and authority to enter into and to
consummate the transactions
contemplated by the Transaction Documents to which it shall be a party and
otherwise
to carry out its obligations thereunder.
3.REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.
As
a
material inducement to each Buyer to enter into this Agreement and purchase
the
Notes
hereunder, the Company represents and warrants to each of the Buyers as of
the
date hereof
that, except as set forth in the Disclosure Schedule attached hereto (the
"Disclosure
Schedule"):
(a)
Organization
and Qualification. The
Company is a corporation duly organized and
validly existing in good standing under the laws of the jurisdiction in which
it
is formed, and has
the
requisite power and authority to own its properties and to carry on its business
as now being
conducted. The Company is duly qualified as a foreign entity to do business
and
is in good
standing in every jurisdiction in which its ownership of property or the nature
of the business
conducted by it makes such qualification necessary, except to the extent that
the failure to
be so
qualified or be in good standing would not have a Material Adverse Effect.
As
used in this
Agreement, "Material
Adverse Effect" means
any
material adverse effect on the business, properties,
assets, operations, results of operations, condition (financial or otherwise)
or
prospects of the Company, or on the transactions contemplated hereby and by
the
other Transaction
Documents or by the agreements and instruments to be entered into in connection
herewith or therewith, or on the authority or ability of the Company to perform
its obligations under
the
Transaction Documents (as defined below). The Company has no
subsidiaries.
6
(b) Authorization;
Enforcement; Validity. Except
as
set forth in Schedule
3(b), the
Company
has the requisite power and authority to enter into and perform its obligations
under this
Agreement, the Notes, the Security Documents, the Irrevocable Transfer Agent
Instructions (in the form of Exhibit E annexed hereto), and each of the other
agreements entered into by the Company
in connection with the transactions contemplated by this Agreement
(collectively, the "Transaction
Documents") and
to
issue the Securities in accordance with the terms hereof and thereof.
The execution and delivery of this Agreement and the other Transaction Documents
by the
Company and the issuance of the Notes has been, and the consummation by the
Company of the
transactions contemplated hereby and thereby, including, without limitation,
the
issuance of the Notes, the reservation for issuance and the issuance of the
Exchange Shares issuable upon exchange of the Notes and the granting of a
security interest in the Collateral (as defined in the Security
Documents), will be prior to Closing, duly authorized by the Company's Board
of
Directors
and (other than (i) the filing of appropriate UCC financing statements with
the
appropriate
states and other authorities pursuant to the Security Agreement, and (ii) the
filing of a
Form D
under Regulation D of the 0000 Xxx) no further filing, consent, or authorization
is required
by the Company, its Board of Directors or its stockholders. This Agreement
and
each of
the
other Transaction Documents of even date herewith has been duly executed and
delivered by the Company and constitutes the legal, valid and binding obligation
of the Company enforceable
against the Company in accordance with its terms, except as such enforceability
may be
limited by general principles of equity or to applicable bankruptcy, insolvency,
reorganization,
moratorium, liquidation and other similar laws relating to, or affecting
generally, the
enforcement of applicable creditors' rights and remedies.
(c) Issuance
of Securities. The
Notes
are duly authorized and are free from all taxes, liens
and
charges with respect to the issue thereof. A number of shares of Common Stock
has been
duly
authorized and reserved for issuance which equals 200% of the maximum number
of
shares
Common Stock issuable upon exchange of the Notes. Upon exchange in accordance
with the
Notes, the Exchange Shares will be validly issued, fully paid and nonassessable
and free from all preemptive or similar rights, taxes, liens and charges with
respect to the issue thereof, with the holders being entitled to all rights
accorded to a holder of Common Stock. Assuming the
truth
and accuracy of the Buyers’ representations and warranties in this Agreement,
the offer to
the
Buyers and issuance by the Company of the Securities is exempt from registration
under the
1933
Act.
(d)
No
Conflicts. The
execution, delivery and performance of this Agreement and the other
Transaction Documents by the Company and the consummation by the Company of
the
transactions contemplated hereby and thereby (including, without limitation,
the
issuance of the Notes,
the granting of a security interest in the Collateral and, reservation for
issuance and issuance
of the Exchange Shares) will not (i) result in a violation of its Certificate
of
Incorporation,
any capital stock or bylaws of the Company (provided that it will not be a
breach of this subsection until a judgment against the Company is obtained)
or
(ii) conflict with, or constitute a default (or an event which with notice
or
lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration
or
cancellation
of, any agreement, indenture or instrument to which the Company is a party,
or
(iii) assuming
the truth and accuracy of the Buyers’ representations and warranties in this
Agreement, result
in
a violation of any law, rule, regulation, order, judgment or decree (including
federal and state
securities laws applicable to the Company or by which any property or asset
of
the Company is bound or affected) except, in the cases of clause (ii) and (iii)
above, for such conflicts,
defaults, rights or violations which would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect.
7
(e) Consents.
The
Company is not required to obtain any consent, authorization or order
of,
or make any filing or registration with, any court, governmental agency or
any
regulatory
or self-regulatory agency or any other Person in order for it to execute,
deliver or perform
any of its obligations under or contemplated by this Agreement or the other
Transaction Documents,
in each case in accordance with the terms hereof or thereof. All consents,
authorizations, orders, filings and registrations which the Company is required
to obtain pursuant to
the
preceding sentence have been obtained or effected on or prior to the Closing
Date, and the Company
is unaware of any facts or circumstances which might prevent the Company from
obtaining
or effecting any of the registration, application or filings pursuant to the
preceding sentence.
(f) Acknowledgment
Regarding Buyer's Purchase of Securities. The
Company acknowledges and agrees that each Buyer is acting solely in the capacity
of an arm's length purchaser
with respect to this Agreement and the other Transaction Documents and the
transactions
contemplated hereby and thereby, and that no Buyer is (i) an officer or director
of the
Company, (ii) to the knowledge of the Company, an "affiliate" of the Company
(as
defined in Rule
144,
an "Affiliate")
or
(iii)
to the knowledge of the Company, a "beneficial owner" of more than
10%
of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the
Securities
Exchange Act of 1934, as amended (the "1934
Act")). The
Company further acknowledges
that no Buyer is acting as a financial advisor or fiduciary of the Company
(or
in any
similar capacity) with respect to this Agreement and the other Transaction
Documents and the
transactions contemplated hereby and thereby, and any advice given by a Buyer
or
any of its representatives
or agents in connection with this Agreement and the other Transaction
Documents
and the transactions contemplated hereby and thereby is merely incidental to
such Buyer's purchase of the Securities. The Company further represents to
each
Buyer that the Company’s decision to enter into the Transaction Documents has
been based solely on the independent evaluation by the Company and its
representatives.
(g)
No
General Solicitation. None
of
the Company, its Affiliates, nor, to the Company’s
knowledge, any Person acting on its or their behalf, has engaged in any form
of
general
solicitation or general advertising (within the meaning of Regulation D) in
connection with the offer or sale of the Securities. The Company shall be
responsible for the payment of any placement agent’s fees, financial advisory
fees, consultancy fees or brokers’ commissions (other
than for persons engaged by any Buyer or its investment advisor) relating to
or
arising out of
the
transactions contemplated hereby. The Company shall pay, and hold each Buyer
harmless against,
any liability, loss or expense (including, without limitation, reasonable
attorney’s fees and
out-of-pocket expenses) arising in connection with any such claim (including
any
claim from the Consultant (as defined below)). The Company acknowledges that
it
has engaged a consultant as
set
out in Schedule 3(g) (the “Consultant”)
in
connection with the sale of the Securities. Other
than the Consultant, the Company has not engaged any placement agent, consultant
or other
agent in connection with the sale of the Securities.
8
(h) No
Integrated Offering. None
of
the Company, its respective Affiliates nor any Person acting on its or their
behalf has, directly or indirectly, made any offers or sales of any security,
or
solicited any offers to buy any security, under circumstances that would require
registration
of any of the Securities under the 1933 Act or cause this offering of the
Securities to be
integrated with prior offerings by the Company for purposes of the 1933 Act
or
any applicable stockholder
approval provisions, including, without limitation, under the rules and
regulations of any
exchange or automated quotation system on which any of the securities of the
Company are listed
or
designated. None of the Company, its Affiliates or any Person acting on its
or
their behalf
will take any action or steps referred to in the preceding sentence that would
require registration
of any of the Securities under the 1933 Act or cause the offering of the
Securities to be
integrated with other offerings in a manner that would require such
registration.
(i) Dilutive
Effect. The
Company understands and acknowledges that the number of Exchange
Shares issuable upon exchange of the Notes will increase in certain
circumstances. The
Company further acknowledges that its obligation to issue Exchange Shares upon
exchange of
the
Notes in accordance with this Agreement and the Notes in accordance with this
Agreement,
is absolute and unconditional regardless of the dilutive effect that such
issuance may have
on
the ownership interests of other stockholders of the Company.
(j) Financial
Statements. Except
as
disclosed in Schedule
3(j), the
financial statements
of the Company annexed hereto as Schedule 3(j), were prepared in accordance
with
generally
accepted accounting principles, consistently applied, during the periods
involved (except
(i) as may be otherwise indicated in such financial statements or the notes
thereto, or (ii) in the case of unaudited interim statements, to the extent
they
may exclude footnotes or may be condensed
or summary statements) and fairly present in all material respects the financial
position
of the Company as of the dates thereof and the results of its operations and
cash flows for
the
periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments).
The Company does not have any material liability other than as set forth in
the
financial
statements, incurred in the ordinary course of business, or as set forth on
Schedule 3(j).
(k) Conduct
of Business; Regulatory Permits. Except
as
set forth in Schedule
3(k), the
Company (i) is not in violation of any term of or in default under its Articles
of Incorporation or
Bylaws
or (ii) is not in violation of any judgment, decree or order or any law,
statute, ordinance,
rule or regulation applicable to the Company. The Company possesses all
certificates,
authorizations and permits issued by the appropriate regulatory authorities
necessary to conduct its business, except where the failure to possess such
certificates, authorizations or permits would not have, individually or in
the
aggregate, a Material Adverse Effect, and the Company
has not received any written notice of proceedings relating to the revocation
or
modification
of any such certificate, authorization or permit.
(l) Foreign
Corrupt Practices. None
of
the Company, nor, to the knowledge of the Company,
any director, officer, agent, or employee, in the course of its actions for,
or
on behalf of,
the
Company (i) used any corporate funds for any unlawful contribution, gift,
entertainment or
other
unlawful expenses relating to political activity; (ii) made any direct or
indirect unlawful payment to any foreign or domestic government official or
employee from corporate funds of the Company;
(iii) violated or is in violation of any provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate,
payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or
employee.
9
(m) Transactions
With Affiliates. Other
than the transactions disclosed on Schedule
3(m), none
of
the officers, directors or employees of the Company is presently a party to
any
transaction
with the Company (other than for ordinary course services as employees, officers
or directors),
including any contract, agreement, loans or other arrangement providing for
the
furnishing
of services to or by, providing for rental of real or personal property to
or
from, including
obligations to pay back pay, salaries, bonuses, etc. or otherwise requiring
payments to or from any such officer, director or employee or, to the knowledge
of the Company, any corporation, partnership, trust or other entity in which
any
such officer, director, or employee has a substantial interest or is an officer,
director, trustee or partner.
(n) Equity
Capitalization. As
of
immediately prior to Closing, the authorized capital stock
of
the Company consists of (i) 48 million shares of Common Stock, of which as
of
the date hereof,
8,417,200 shares are issued and outstanding, and (ii) 36 million shares of
Preferred Stock,
of
which as of the date hereof (A) 12 million are classified as Series A Preferred
Stock, of which
as
of the date hereof, 9,440,200 are issued and outstanding and (B) 24 million
are
classified
as Series B Preferred Stock, of which as of the date hereof 10,414,653.9423
are
issued and
outstanding. All currently issued and outstanding shares of Common Stock have
been, or upon
issuance will be, validly issued and are fully paid and nonassessable. Except
as
disclosed herein or as disclosed in Schedule
3(n): (i)
none
of the Company's capital stock is subject to preemptive rights or any other
similar rights or any liens or encumbrances suffered or permitted by
the
Company; (ii) there are no outstanding options, warrants, scrip, rights to
subscribe to, calls
or
commitments of any character whatsoever relating to, or securities or rights
convertible into, or exercisable or exchangeable for, any capital stock of
the
Company, or contracts, commitments,
understandings or arrangements by which the Company is or may become bound
to
issue
additional capital stock of the Company or options, warrants, scrip, rights
to
subscribe to,
calls
or commitments of any character whatsoever relating to, or securities or rights
convertible
into, or exercisable or exchangeable for, any capital stock of the Company;
(iii) there are
no
outstanding debt securities, notes, credit or loan agreements, credit facilities
or other agreements,
documents or instruments evidencing Indebtedness (as defined below) of the
Company
or by which the Company is bound or may be affected; (iv) there are no financing
statements
securing obligations in any material amounts, either singly or in the aggregate,
filed in connection
with the Company; (v) there are no agreements or arrangements under which the
Company is obligated to register the sale of any of their securities under
the
1933 Act; (vi) there are no outstanding securities or instruments of the Company
which contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which
the
Company is or may become bound to purchase, repurchase, retire or redeem a
security of
the
Company; (vii) there are no securities or instruments containing anti-dilution
or similar provisions
or reset provisions that will be triggered by the issuance of the Securities;
and (viii) the
Company does not have any stock appreciation rights or "phantom stock" plans
or
agreements
or any similar plan or agreement. The Company has furnished to the Buyer true,
correct
and complete copies of the Company's Articles of Incorporation, as amended
and
as in effect on the date hereof (the "Articles
of Incorporation"), and
the
Company's Bylaws, as amended and as in effect on the date hereof (the
"Bylaws"),
and
the
terms of all securities convertible
into, or exercisable or exchangeable for, shares of Common Stock and the
material rights
of
the holders thereof.
10
(o)
Indebtedness
and Other Contracts. Except
as
disclosed in Schedule
3(o), the
Company
(i) has no outstanding Indebtedness (as defined below), (ii) is not a party
to
any contract,
agreement or instrument, the violation of which, or default under which, by
the
other party(ies)
to such contract, agreement or instrument would result in a Material Adverse
Effect, (iii)
is
not in violation of any term of or in default under any contract, agreement
or
instrument relating to any Indebtedness, except where such violations and
defaults would not result, individually
or in the aggregate, in a Material Adverse Effect, or (iv) is not a party to
any
contract,
agreement or instrument relating to any Indebtedness, the performance of which,
in the judgment
of the Company's officers, has or is expected to have a Material Adverse Effect.
Schedule
3(p) provides
a detailed description of the material terms of any such outstanding
Indebtedness.
For purposes of this Agreement: (x) "Indebtedness"
of
any
Person means, without
duplication (A) all indebtedness for borrowed money, (B) all obligations issued,
undertaken
or assumed as the deferred purchase price of property or services including
(without limitation)
"Capital Leases" in accordance with generally accepted accounting principles
(other than
trade payables entered into in the ordinary course of business), (C) all
reimbursement or payment obligations with respect to letters of credit, surety
bonds and other similar instruments, (D) all obligations evidenced by notes,
bonds, debentures or similar instruments, including obligations
so evidenced incurred in connection with the acquisition of property, assets
or
businesses,
(E) all indebtedness created or arising under any conditional sale or other
title retention
agreement, or incurred as financing, in either case with respect to any property
or assets acquired
with the proceeds of such indebtedness (even though the rights and remedies
of
the seller
or
bank under such agreement in the event of default are limited to repossession
or
sale of such
property), (F) all monetary obligations under any leasing or similar arrangement
which, in connection
with generally accepted accounting principles, consistently applied for the
periods covered thereby, is classified as a capital lease, (G) all indebtedness
referred to in clauses (A) through
(F) above secured by (or for which the holder of such Indebtedness has an
existing right, contingent
or otherwise, to be secured by) any mortgage, lien, pledge, charge, security
interest or other
encumbrance upon or in any property or assets (including accounts and contract
rights) owned
by
any Person, even though the Person which owns such assets or property has not
assumed
or become liable for the payment of such indebtedness, and (H) all Contingent
Obligations
in respect of indebtedness or obligations of others of the kinds referred to
in
clauses (A)
through (G) above; (y) "Contingent
Obligation" means,
as
to any Person, any direct or indirect
liability, contingent or otherwise, of that Person with respect to any
indebtedness, lease, dividend
or other obligation of another Person if the primary purpose or intent of the
Person incurring
such liability, or the primary effect thereof, is to provide assurance to the
obligee of such
liability that such liability will be paid or discharged, or that any agreements
relating thereto will be complied with, or that the holders of such liability
will be protected (in whole or in part) against loss with respect thereto;
and
(z) "Person"
means
an
individual, a limited liability company,
a partnership, a joint venture, a corporation, a trust, an unincorporated
organization and
a
government or any department or agency thereof.
11
(p) Absence
of Litigation. There
is
no action, suit, proceeding, inquiry or investigation before or by any court,
public board, government agency, self-regulatory organization
or body pending or, to the knowledge of the Company, threatened against or
affecting the Company, the Common Stock or any of the or any of the Company's
officers or directors, except as set forth in Schedule
3(p).
(q) Insurance.
The
Company is insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as management of the Company
believes
to be prudent and customary in the businesses in which the Company is engaged.
The Company has not, within the past two (2) years, been refused any insurance
coverage sought or applied for.
(r)Employee
Relations.
(i) The
Company is not a party to any collective bargaining agreement and does
not
employ any member of a union. Except as disclosed in Schedule 3(r), no executive
officer of the
Company (as defined in Rule 501(f) of the 0000 Xxx) has notified the Company
that such officer
intends to leave the Company or otherwise terminate such officer's employment
with the Company.
No executive officer of the Company, to the knowledge of the Company, is in
violation
of any material term of any employment contract, confidentiality, disclosure
or
proprietary
information agreement, non-competition agreement, or any other contract or
agreement
or any restrictive covenant, and the continued employment of each such executive
officer
does not subject the Company to any liability with respect to any of the
foregoing matters.
(ii) The
Company is in compliance with all federal, state, local and foreign laws
and
regulations respecting labor, employment and employment practices and benefits,
terms and conditions
of employment and wages and hours, except where failure to be in compliance
would not,
either individually or in the aggregate, reasonably be expected to result in
a
Material Adverse
Effect.
(s)
Title.
Except
as
disclosed in Schedule
3(s), the
Company has good and marketable
title in fee simple to all real property owned by it and good and marketable
title to all personal
property owned by it which is, in each case, material to the business of the
Company, free
and
clear of all liens, encumbrances and defects except such as do not materially
affect the value
of
such property and do not interfere with the use made and proposed to be made
of
such property by the Company. Any real property and facilities held under lease
by the Company is held
by
them under valid, subsisting and enforceable leases with such exceptions as
are
not material
and do not interfere with the use made and proposed to be made of such property
and facilities by the Company.
(t)
Intellectual
Property Rights. The
Company owns or possesses adequate rights or licenses
to use all trademarks, trade names, service marks, service xxxx registrations,
service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations,
trade secrets and other intellectual property rights necessary to conduct its
business
as now conducted and as proposed to be conducted ("Intellectual
Property Rights"), provided,
that
the
representation in this sentence shall not apply to mechanical publishing rights.
Except
as
set forth in Schedule
3(t), none
of
the Company's Intellectual Property Rights have expired
or terminated, or are expected to expire or terminate, within three years from
the date of this
Agreement. The Company does not have any knowledge of any infringement by the
Company
of Intellectual Property Rights of others. There is no claim, action or
proceeding being made
or
brought or, to the knowledge of the Company, being threatened, against the
Company regarding its Intellectual Property Rights. The Company (x) is unaware
of any facts or circumstances
which might give rise to any of the foregoing infringements or claims, actions
or proceeding,
except as set forth in the proviso to the first sentence of this Section and
(y)
has taken
reasonable security measures to protect the secrecy, confidentiality and value
of all of its Intellectual Property Rights.
12
(u) Environmental
Laws. The
Company (i) is in compliance with any and all Environmental Laws (as hereinafter
defined), (ii) has received all permits, licenses or other approvals required
of
them under applicable Environmental Laws to conduct its respective businesses
and (iii) is in compliance with all terms and conditions of any such permit,
license or approval
where, in each of the foregoing clauses (i), (ii) and (iii), the failure to
so
comply could be
reasonably expected to have, individually or in the aggregate, a Material
Adverse Effect. The term
"Environmental
Laws" means
all
federal, state, local or foreign laws relating to pollution or
protection of human health or the environment (including, without limitation,
ambient air, surface
water, groundwater, land surface or subsurface strata), including, without
limitation, laws relating
to emissions, discharges, releases or threatened releases of chemicals,
pollutants, contaminants, or toxic or hazardous substances or wastes
(collectively, "Hazardous
Materials") into
the
environment, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations,
codes, decrees, demands or demand letters, injunctions, judgments, licenses,
notices
or notice letters, orders, permits, plans or regulations issued, entered,
promulgated or approved thereunder.
(v) Investment
Company. The
Company is not, and is not an Affiliate of, an "investment
company" within the meaning of the Investment Company Act of 1940, as
amended.
(w)
Tax
Status. Except
as
disclosed on Schedule
3(w), the
Company (i) has made or filed
all
foreign, federal and state income and all other tax returns, reports and
declarations required
by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments
and charges that are material in amount, shown or determined to be due on such
returns,
reports and declarations, except those being contested in good faith and (iii)
has set aside on its books provision reasonably adequate for the payment of
all
taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. Except as
disclosed on Schedule
3(w), there
are
no unpaid taxes in any material amount claimed to be due by the taxing authority
of any jurisdiction, and the officers of the Company know of no basis for any
such claim. Except as disclosed on Schedule
3(w), no
liens
have been filed and no claims are being asserted by or against
the Company with respect to any taxes (other than liens for taxes not yet due
and payable).
The Company has not received notice of assessment or proposed assessment of
any
taxes
of
a material amount claimed to be owed by it or any other Person on its behalf.
Except as disclosed on Schedule
3(w), the
Company is not a party to any tax sharing or tax indemnity agreement
or any other agreement of a similar nature that remains in effect. Except as
disclosed on
Schedule
3(w), the
Company has complied in all material respects with all applicable legal
requirements
relating to the payment and withholding of taxes and, within the time and in
the
manner
prescribed by law, has withheld from wages, fees and other payments and paid
over to the
proper governmental or regulatory authorities all amounts
required.
13
(x) Ranking
of Notes. Except
as
set forth on Schedule
3(x), no
Indebtedness of the Company
is senior to or ranks pari
passu with
the
Notes in right of payment, whether with respect
of payment of redemptions, interest, damages or upon liquidation or dissolution
or otherwise.
(y) Transfer
Taxes. On
the
Closing Date, all stock transfer or other taxes (other than income
or
similar taxes) which are required to be paid in connection with the sale and
transfer of the
Securities to be sold to each Buyer hereunder will be, or will have been, fully
paid or provided
for by the Company, and all laws imposing such taxes will be or will have been
complied
with.
(z)
U.S.
Real Property Holding Corporation. The
Company is not, nor has ever been, a
U.S.
real property holding corporation within the meaning of Section 897 of the
Internal Revenue
Code of 1986, as amended, and the Company shall so certify upon Buyer's
request.
4.COVENANTS.
(a) Best
Efforts. Each
party shall use its best efforts timely to satisfy each of the conditions
to be satisfied by it as provided in Sections 6 and 7 of this
Agreement.
(b) Form
D
and Blue Sky. The
Company agrees to file a Form D with respect to the Securities
as required under Regulation D and to provide a copy thereof to each Buyer
promptly after
such filing. The Company shall make all filings and reports relating to the
offer and sale of the
Securities required under applicable securities or “Blue Sky” laws of the states
of the United States,
whether before or after the Closing Date.
(c)
Reporting
Status. After
the
date on which the Company is required to file periodic
reports with the SEC pursuant to the 1934 Act and until the date on which the
Holders shall
have sold a sufficient number of shares such that, collectively, they own less
than 5% of the total
outstanding shares of common stock of the Company (the "Reporting
Period"), the
Company
shall file all reports, schedules, forms, statements and other documents
required to be filed
by
it with the SEC pursuant to the reporting requirements of the 1934 Act (all
of
the foregoing
filed prior to the date hereof and all exhibits included therein and financial
statements, notes
and
schedules thereto and documents incorporated by reference therein being
hereinafter referred
to as the "SEC
Documents") and
the
Company shall not terminate its status as an issuer required
to file reports under the 1934 Act even if the 1934 Act or the rules and
regulations thereunder would otherwise permit such termination.
14
(d) Use
of
Proceeds. The
Company will use the proceeds from the sale of the Securities
as set forth on Schedule
4(d).
(e) Transfer
Agent Instructions. The
Company shall file a Form 10SB (or similar form)
within 45 days following the Closing and shall use its best efforts to have
it
declared effective
as soon as possible. Upon the earlier of effectiveness of such Form 1 0SB or
sixty (60) days
following its filing with the SEC, the Company shall employ the services of
Continental Stock Transfer and Trust Co. as its designated transfer agent
(“Transfer
Agent”) and
execute and
cause
it to execute the Irrevocable Transfer Agent Instructions in substantially
similar form to
Exhibit
E, attached
hereto.
(f) [
Reserved. ]
(g) Fees.
The
Company shall pay (i) to Gottbetter & Partners, LLP (“G&P”),
an
hourly
fee for the preparation of the Transaction Documents; (ii) to G&P, $5,000
plus its usual hourly
rates for serving as escrow agent, and (iii) to Gottbetter Capital Finance,
LLC., $10,000 for
serving as Collateral Agent, all plus reasonable expenses which shall be
withheld by such Buyer from its Purchase Price at the Closing. The Company
shall
be responsible for the payment of any placement agent's fees, financial advisory
fees, consultancy fees or broker's commissions (other than for Persons engaged
by any Buyer) relating to or arising out of the transactions contemplated
by the Transaction Documents including, without limitation, any fees or
commission
payable to the Consultant. The Company shall pay, and hold each Buyer harmless
against,
any liability, loss or expense (including, without limitation, reasonable
attorney's fees and
out-of-pocket expenses) arising in connection with any claim against a Buyer
relating to any such
payment. Except as otherwise set forth in the Transaction Documents, each party
to this Agreement
shall bear its own expenses in connection with the sale of the Securities to
the
Buyers.
(h) Pledge
of Securities. The
Company acknowledges and agrees that the Securities may
be
pledged by a Buyer in connection with a bona fide margin agreement or other
loan
or financing arrangement that is secured by the Securities. The pledge of
Securities shall not be deemed to be a transfer, sale or assignment of the
Securities hereunder, and no Buyer effecting a pledge
of
Securities shall be required to provide the Company with any notice thereof
or
otherwise
make any delivery to the Company pursuant to this Agreement or any other
Transaction
Document, including, without limitation, Section 2(f) hereof; provided that
a
Buyer and
its
pledgee shall be required to comply with the provisions of Section 2(f) hereof
in order to effect
a
sale, transfer or assignment of Securities to such pledgee. The Company hereby
agrees to
execute and deliver such documentation as a pledgee of the Securities may
reasonably request in connection with a pledge of the Securities to such pledgee
by a Buyer.
(i) [
Reserved. ]
(j)
Restriction
on Redemption and Cash Dividends. So
long
as any Notes are outstanding,
the Company shall not, directly or indirectly, redeem, or declare or pay any
cash dividend or distribution on, the Common Stock without the prior express
written consent of the Required Holders (as defined in the Notes).
15
(k) Additional
Notes; Variable Securities; Dilutive Issuances. So
long
as any Buyer beneficially
owns any Securities, the Company will not issue any Notes (other than as
contemplated hereby) and the Company shall not issue any other securities that
would cause a breach
or
default under the Notes. For so long as any Notes remain outstanding, the
Company shall
not, in any manner, issue or sell any rights, warrants or options to subscribe
for or purchase Common
Stock or other securities directly or indirectly convertible into or
exchangeable or exercisable for Common Stock at a price which varies or may
vary
with the market price of the Common
Stock, including by way of one or more reset(s) to any fixed price unless the
conversion,
exchange or exercise price of any such security cannot be less than the then
applicable Exchange Price (as defined in the Notes) with respect to the Common
Stock into which any Note is exchangeable. For so long as any Notes remain
outstanding, the Company shall
not, in any manner, enter into or affect any Dilutive Issuance (as defined
in
the Notes) if the effect
of
such Dilutive Issuance is to cause the Company to be required to issue upon
exchange of
any
Note any shares of Common Stock in excess of that number of shares of Common
Stock which
the
Company has authorized and reserved for purposes of such exchanges or exercises
or which the Company may issue upon exchange of the Notes.
(l) Corporate
Existence. So
long
as any Buyer beneficially owns any Securities, the Company shall not be party
to
any Fundamental Transaction (as defined in the Notes) unless the Company
is in compliance with the applicable provisions governing Fundamental
Transactions set
forth
in the Notes.
(m) Reservation
of Shares. So
long
as any Buyer owns any Securities, the Company shall take all action necessary
to
at all times have authorized, and reserved for the purpose of issuance,
no less than 200% of the number of shares of Common Stock issuable upon exchange
of
all of
the Notes then outstanding (without taking into account any limitations on
the
exchange of the Notes).
(n) [
Reserved. ]
(o) Additional
Issuances of Securities.
(i) For
purposes of this Section 4(o), the following definitions shall
apply.
(1) "Convertible
Securities" means
any
stock or securities (other than Options)
convertible into or exercisable or exchangeable for shares of Common
Stock.
(2) "Options"
means
any
rights, warrants or options to subscribe for or
purchase shares of Common Stock or Convertible Securities.
(3) "Common
Stock Equivalents" means,
collectively, Options and
Convertible
Securities.
(ii)
From
the date hereof until the date that is one year after the Company is
required
to file reports with the SEC (the "Trigger
Date"), and
except with respect to any transaction
described in Schedule
4(o) or
with
respect to any issuance to an officer, director
or employee pursuant to an employee or director stock incentive plan or with
respect
to an issuance of Excluded Securities (as defined in the Notes), the Company
will not,
directly or indirectly, offer, sell, grant any option to purchase, or otherwise
dispose of (or announce any offer, sale, grant or any option to purchase or
other disposition of) any
of
its equity or equity equivalent securities, including without limitation any
debt, preferred
stock or other instrument or security that is, at any time during its life
and
under any
circumstances, convertible into or exchangeable or exercisable for shares of
Common Stock
or
Common Stock Equivalents (any such offer, sale, grant, disposition or
announcement
being referred to as a "Subsequent
Placement"), unless
the Company shall
have complied with Section 4(o)(iii).
16
(iii)
Prior to the Trigger Date, the Company will not, directly or indirectly,
effect
any Subsequent Placement unless the Company shall have first complied with
this
Section 4(o)(iii).
(1) The
Company shall deliver to each Buyer who still holds Notes a written
notice (the "Offer
Notice") of
any
proposed or intended issuance or sale or
exchange (the "Offer")
of
the
securities being offered (the "Offered
Securities")
in
a
Subsequent Placement, which Offer Notice shall (w) identify and
describe the Offered Securities, (x) describe the price and other terms upon
which they are to be issued, sold or exchanged, and the number or amount of
the
Offered
Securities to be issued, sold or exchanged, (y) identify the persons or
entities
(if known) to which or with which the Offered Securities are to be offered,
issued, sold or exchanged and (z) offer to issue and sell to or exchange
with
such
Buyers all of the Offered Securities, allocated among such Buyers (a)
based
on
such Buyer's pro rata portion of the aggregate principal amount of Notes
purchased
hereunder (the "Basic
Amount"), and
(b)
with respect to each Buyer that
elects to purchase its Basic Amount, any additional portion of the Offered
Securities attributable to the Basic Amounts of other Buyers as such Buyer
shall
indicate it will purchase or acquire should the other Buyers subscribe for
less
than their Basic Amounts (the "Undersubscription
Amount").
(2) To
accept
an Offer, in whole or in part, such Buyer must deliver a written notice to
the
Company prior to the end of the tenth (10th)
day
after such Buyer's
receipt of the Offer Notice (the "Offer
Period"), setting
forth the portion of
such
Buyer's Basic Amount that such Buyer elects to purchase and, if such Buyer
shall
elect to purchase all of its Basic Amount, the Undersubscription Amount,
if any, that such Buyer elects to purchase (in either case, the "Notice
of Acceptance").
If
the
Basic Amounts subscribed for by all Buyers are less than the
total
of all of the Basic Amounts, then each Buyer who has set forth an Undersubscription
Amount in its Notice of Acceptance shall be entitled to purchase,
in addition to the Basic Amounts subscribed for, the Undersubscription Amount
it
has subscribed for; provided,
however, that
if
the Undersubscription Amounts subscribed for exceed the difference between
the
total of all the Basic Amounts
and the Basic Amounts subscribed for (the "Available
Undersubscription
Amount"), each
Buyer who has subscribed for any Undersubscription
Amount shall be entitled to purchase only that portion of the Available
Undersubscription Amount as the Basic Amount of such Buyer bears to the
total
Basic Amounts of all Buyers that have subscribed for Undersubscription Amounts,
subject to rounding by the Company to the extent its deems reasonably
necessary.
17
(3) The
Company shall have thirty (30) Business Days from the expiration
of the Offer Period above to offer, issue, sell or exchange all or any
part
of
such Offered Securities as to which a Notice of Acceptance has not been
given
by
the Buyers (the "Refused
Securities"), but
only
to the offerees described in
the
Offer Notice (if so described therein) or any investor introduced to the
Company
by a placement agent described in the Offer Notice and only upon terms
and
conditions (including, without limitation, unit prices and interest rates)
that
are
not
more favorable to the acquiring person or persons or less favorable to the
Company
than those set forth in the Offer Notice.
(4) In
the
event the Company shall propose to sell less than all the Refused
Securities (any such sale to be in the manner and on the terms specified
in
Section 4(o)(iii)(3) above), then each Buyer may, at its sole option and in
its
sole discretion, reduce the number or amount of the Offered Securities specified
in
its
Notice of Acceptance to an amount that shall be not less than the number or
amount of the Offered Securities that such Buyer elected to purchase pursuant
to
Section
4(o)(iii)(2) above multiplied by a fraction, (i) the numerator of which
shall
be
the number or amount of Offered Securities the Company actually proposes
to issue, sell or exchange (including Offered Securities to be issued or
sold
to
Buyers pursuant to Section 4(o)(iii)(3) above prior to such reduction) and
(ii)
the
denominator of which shall be the original amount of the Offered Securities.
In the event that any Buyer so elects to reduce the number or amount
of
Offered Securities specified in its Notice of Acceptance, the Company may not
issue, sell or exchange more than the reduced number or amount of the Offered
Securities
unless and until such securities have again been offered to the Buyers
in
accordance with Section 4(o)(iii)(1) above.
(5) Upon
the
closing of the issuance, sale or exchange of all or less than all of the Refused
Securities, the Buyers shall acquire from the Company, and
the
Company shall issue to the Buyers, the number or amount of Offered Securities
specified in the Notices of Acceptance, as reduced pursuant to Section
4(o)(iii)(3)
above if the Buyers have so elected, upon the terms and conditions specified
in the Offer Notice. The purchase by the Buyers of any Offered Securities
is subject in all cases to the preparation, execution and delivery by the
Company
and the Buyers of a purchase agreement relating to such Offered Securities
reasonably satisfactory in form and substance to the Buyers and their respective
counsel and to the Company and its counsel.
(6) Any
Offered Securities not acquired by the Buyers or other persons in
accordance with Section 4(o)(iii)(3) above may not be issued, sold or exchanged
until they are again offered to the Buyers under the procedures specified
in this Agreement.
18
(iv)
The
restrictions contained in subsections (ii) and (iii) of this Section 4(o)
shall
not
apply in connection with the issuance of any Excluded Securities (as defined
in
the Notes).
(p) Additional
Registration Statements. Until
the
Effective Date (as defined in the Registration
Rights Agreement), the Company will not file a registration statement under
the
1933
Act
relating to securities that are not the Securities.
(q) No
Short Position. For
so
long as the Notes remain outstanding, none of the
Buyers
or
any of its Affiliates shall have an open short position in the Common
Stock.
(r) [reserved]
(s) Transactions
With Affiliates. So
long
as any Note is outstanding, the Company shall
not
enter into, amend, modify or supplement any agreement, transaction, commitment,
or arrangement with any of its officers, directors, persons who were officers
or
directors as of the Issue
Date, stockholders who beneficially own five percent (5%) or more of the Common
Stock, or
Affiliates (as defined below), or with any individual related by blood,
marriage, or adoption to any
such
individual or with any entity in which any such entity or individual owns a
five
percent (5%)
or
more beneficial interest (each a "Related
Party"), except
(a) for customary employment arrangements
and benefit programs on reasonable terms, or (b) relating to the transactions
described
in Schedule
4(s). For
purposes of this Section 4(s) only, "Affiliate" means, with respect
to any person or entity, another person or entity that, directly or indirectly,
(i) has a ten percent (10%) or more equity interest in that person or entity,
(ii) has ten percent (10%) or more common ownership with that person or entity,
(iii) controls that person or entity, or (iv) shares common
control with that person or entity. "Control" or "controls" for purposes hereof
means that
a
person or entity has the power, direct or indirect, to conduct or govern the
policies of another
person or entity.
(t)
Collateral
Agent.
(i)
Each
Buyer hereby (a) appoints Gottbetter Capital Finance, LLC as the
collateral agent hereunder and under the other Security Documents (in such
capacity, the “Collateral
Agent”), and
(b)
authorizes the Collateral Agent (and its officers, directors, employees
and agents) to take such action on such Buyer’s behalf in accordance with the
terms hereof and thereof. The Collateral Agent shall not have, by reason hereof
or any of the other Security
Documents, a fiduciary relationship in respect of any Buyer. Neither the
Collateral Agent
nor
any of its officers, directors, employees and agents shall have any liability
to
any Buyer
for
any action taken or omitted to be taken in connection hereof or any other
Security Document
except to the extent caused by its own gross negligence or willful misconduct,
and each
Buyer agrees to defend, protect, indemnify and hold harmless the Collateral
Agent and all of
its
officers, directors, employees and agents (collectively, the “Collateral
Agent Indemnitees”)
from
and
against any losses, damages, liabilities, obligations, penalties, actions,
judgments,
suits, fees, costs and expenses (including, without limitation, reasonable
attorneys’ fees,
costs and expenses) incurred by such Collateral Agent Indemnitee, whether
direct, indirect or
consequential, arising from or in connection with the performance by such
Collateral Agent Indemnitee
of the duties and obligations of Collateral Agent pursuant hereto or any of
the
Security
Documents.
19
(ii) The
Collateral Agent shall be entitled to rely upon any written notices,
statements, certificates, orders or other documents believed by it in good
faith
to be genuine and correct and to have been signed, sent or made by the proper
Person, and with respect to
all
matters pertaining to this Agreement or any of the other Transaction Documents
and its duties
hereunder or thereunder, upon advice of counsel selected by it.
(iii) The
Collateral Agent may resign from the performance of all its functions and duties
hereunder and under the Notes and the Security Documents at any time by
giving
at
least ten (10) Business Days prior written notice to the Company and each holder
of the Notes.
Such resignation shall take effect upon the acceptance by a successor Collateral
Agent of appointment
as provided below. Upon any such notice of resignation, the holders of a
majority of
the
outstanding principal under the Notes shall appoint a successor Collateral
Agent. Upon the
acceptance of the appointment as Collateral Agent, such successor Collateral
Agent shall succeed to and become vested with all the rights, powers, privileges
and duties of the retiring Collateral
Agent, and the retiring Collateral Agent shall be discharged from its duties
and
obligations
under this Agreement, the Notes and the other Security Documents. After any
Collateral
Agent’s resignation hereunder, the provisions of this Section 4(t) shall inure
to its benefit.
If a successor Collateral Agent shall not have been so appointed within said
ten
(10) Business
Day period, the retiring Collateral Agent shall then appoint a successor
Collateral Agent
who
shall serve until such time, if any, as the holders of a majority of the
outstanding principal under the Notes appoint a successor Collateral Agent
as
provided above.
(u) Appointment
of Directors. So
long
as any of the Notes remain outstanding or the original
purchasers of the Notes beneficially own at least 5% of the Common Stock of
the
Company,
calculated in accordance with Section 13(d) of the 1934 Act and Regulation
13D-G
thereunder, the Required Holders (as defined in the Notes) shall have the right
to nominate two individuals to the Company’s Board of Directors, the initial
nominees being Xxxxx X. Xxxxx and Xxxx Xxxx. The Company shall use its best
efforts to cause such nominees to be elected to the Board
of
Directors of the Company. Such nominees agree to resign as directors when none
of the
Notes
remain outstanding and the original purchasers of the Notes beneficially own
less than 5%
of the
Common Stock of the Company calculated in accordance with Section 13(d) of
the
1934
Act
and Regulation 13D-G thereunder.
(v) Proxy
and Voting. Buyers
agree that in connection with meetings of stockholders,
they shall grant the Company a proxy, on a pro rata basis based upon the total
number
of
shares owned, to vote any shares owned by them in excess of 20%, collectively,
of the total
outstanding shares of voting stock of the Company.
5. [
Reserved. ]
20
6. CONDITIONS
TO THE COMPANY'S OBLIGATION TO SELL.
The
obligation of the Company hereunder to issue and sell the Notes to each Buyer
and to otherwise
cause the transactions contemplated by this Agreement to be consummated is
subject to the satisfaction, at or before the Closing Date, of each of the
following conditions, provided that
these conditions are for the Company's sole benefit and may be waived by the
Company at any time in its sole discretion by providing each Buyer with prior
written notice thereof:
(i) Such
Buyer and each other Buyer shall have executed each of the Transaction
Documents to which it is a party and delivered the same to the
Company.
(ii) Such
Buyer and each other Buyer shall have delivered to the Company the Purchase
Price less any amount withheld in satisfaction of the Company's obligations
pursuant to Section 4(g) for the Notes being purchased by such Buyer at the
Closing or Subsequent
Closing by wire transfer of immediately available funds pursuant to the wire
instructions
provided by the Company.
(iii) The
representations and warranties of each Buyer shall be true and correct
with
respect to those matters that are qualified by material adverse effect or by
any
other materiality
standard and shall be true and correct in all material respects with respect
to
all
matters that are not so qualified, in each case as of the date hereof and as
of
the Closing
Date as though made at that time (except to the extent any such representation
or warranty
expressly speaks as of an earlier date, in which case such representation and
warranty
shall be true and correct or true and correct in all material respects, as
applicable,
as of such earlier date), and each Buyer shall have performed, satisfied and
complied in all material respects with the covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied
with by such Buyer at or prior to the Closing Date.
(iv) The
Company shall have obtained all governmental, regulatory or third party
consents and approvals, if any, necessary for the sale of the
Securities.
(v) No
temporary restraining order, preliminary or permanent injunction or other order
preventing the consummation of the transaction contemplated by this Agreement
shall have been issued by any court of competent jurisdiction or other
government
body and remain in effect, and there shall not be any legal requirement
enacted
or deemed applicable to the transactions contemplated hereby that makes the
consummation of such transactions illegal.
(vi) Each
Buyer shall have delivered to the Company such other documents relating
to the transactions contemplated by this Agreement as the Company or its
counsel
may reasonably request.
7.
CONDITIONS
TO EACH BUYER'S OBLIGATION TO PURCHASE.
The
obligation of each Buyer hereunder to purchase the Notes at the Closing is
subject to the
satisfaction, at or before the Closing Date, of each of the following
conditions, provided that these conditions are for each Buyer's sole benefit
and
may be waived by such Buyer at any time in
its
sole discretion by providing the Company with prior written notice
thereof:
21
(i) The
Company shall have executed and delivered to such Buyer (A) each of
the
Transaction Documents and (B) the Notes (in such principal amounts as such
Buyer
shall request) being purchased by such Buyer at the Closing pursuant to this
Agreement;
(ii) The
Company shall have delivered to such Buyer a certificate, executed by the
Corporate Secretary of the Company and dated as of the Closing Date, as to
(i)
the resolutions
consistent with Section 3(b), including the election of Xxxxx X. Xxxxx and
Xxxx
Xxxx
to the Board of Directors of the Company in a form reasonably acceptable to
such
Buyer, (ii) the Certificate of Incorporation and (iii) the Bylaws, each as
in
effect at the
Closing, in the form attached hereto as Exhibit
F.
(iii) The
representations and warranties of the Company shall be true and correct
in all material respects (other than representations and warranties that are
already qualified
by materiality or Material Adverse Effect which shall be true and correct in
all
respects)
as of the date when made and as of the Closing Date as though made at that
time
(except for representations and warranties that speak as of a specific date)
and
the Company
shall have performed, satisfied and complied in all respects with the covenants,
agreements
and conditions required by the Transaction Documents to be performed, satisfied
or complied with by the Company at or prior to the Closing Date. Such Buyer
shall have received a certificate, executed by the Corporate Secretary of the
Company, dated
as
of the Closing Date, to the foregoing effect and as to such other matters as
may
be
reasonably requested by such Buyer.
(iv) The
Company shall have obtained all governmental, regulatory or third party
consents and approvals, if any, necessary for the sale of the
Securities.
(vii) The
following persons shall have pledged and delivered the following number
of
shares of Common Stock or shares convertible into Common Stock as existing
on
or
before February 14, 2007 to Gottbetter Capital Finance, LLC, as collateral
agent
under
one
Pledge Agreement:
Xxxxx
Xxxxxxxx
|
120,000
|
Xxxx
Xxxxxxx
|
120,000
|
Xxx
Xxxxxx
|
50,000
|
Xxxxxxx
Xxxxxx
|
200,000
|
Xxxxxxxxxxx
XxXxxxxx
|
150,000
|
Xxxxxx
X. Xxxxx
|
3,381,000
|
(viii) Prior
to
Closing, the Company shall have delivered or caused to be delivered
to each Buyer (A) true copies of UCC search results, listing all effective
financing statements
which name the Company as debtor filed in the prior five years to perfect an
interest in
any
assets thereof, together with copies of such financing statements, none of
which, except as otherwise
agreed in writing by the Buyers, shall cover any Collateral (as defined in
the
Security
22
Documents)
and the results of searches for any tax lien and judgment lien filed against
the
Company or its property, which results, except as otherwise agreed to in writing
by the Buyers, shall not show any such Liens (as defined in the Security
Documents).
8. TERMINATION.
This
Agreement may be terminated prior to the Closing Date by mutual written consent
of
the
Company and each Buyer. If this Agreement is terminated pursuant to this Section
8, the Company
shall remain obligated to reimburse the non-breaching Buyers for the expenses
described
in Section 4(g) above.
9. MISCELLANEOUS.
(a) Governing
Law; Jurisdiction; Jury Trial. All
questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed
by
the internal
laws of the State of New York, without giving effect to any choice of law or
conflict of law provision or rule (whether of the State of New York or any
other
jurisdictions) that would cause
the
application of the laws of any jurisdictions other than the State of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the
state
and federal courts sitting
in The City of New York, Borough of Manhattan, for the adjudication of any
dispute hereunder
or in connection herewith or with any transaction contemplated hereby or
discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action
or
proceeding, any
claim
that it is not personally subject to the jurisdiction of any such court, that
such suit, action
or
proceeding is brought in an inconvenient forum or that the venue of such suit,
action or proceeding
is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding
by
mailing a copy thereof to
such
party at the address for such notices to it under this Agreement and agrees
that
such service
shall constitute good and sufficient service of process and notice thereof.
Nothing contained
herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. EACH
PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO
REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT
OR ANY TRANSACTION CONTEMPLATED HEREBY.
(b) Counterparts.
This
Agreement may be executed in two or more identical counterparts, all of which
shall be considered one and the same agreement and shall become effective when
counterparts have been signed by each party and delivered to the other party;
provided that a facsimile signature shall be considered due execution and shall
be binding upon the signatory thereto with the same force and effect as if
the
signature were an original, not a facsimile signature.
(c) Headings.
The
headings of this Agreement are for convenience of reference and shall
not
form part of, or affect the interpretation of, this Agreement.
(d) Severability.
If
any
provision of this Agreement shall be invalid or unenforceable in
any
jurisdiction, such invalidity or unenforceability shall not affect the validity
or enforceability
of the remainder of this Agreement in that jurisdiction or the validity or
enforceability of any provision of this Agreement in any other
jurisdiction.
23
(e) Entire
Agreement; Amendments. This
Agreement and the other Transaction Documents
supersede all other prior oral or written agreements between the Buyers, the
Company,
their Affiliates and Persons acting on their behalf with respect to the matters
discussed herein,
and this Agreement, the other Transaction Documents and the instruments
referenced herein and therein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as
specifically set forth herein or therein, neither the Company
nor any Buyer makes any representation, warranty, covenant or undertaking with
respect
to such matters. No provision of this Agreement may be amended other than by
an
instrument in writing signed by the Company and the Required Holders, and any
amendment to this
Agreement made in conformity with the provisions of this Section 9(e) shall
be
binding on all
Buyers and holders of securities, as applicable. No provision hereof may be
waived other than
by
an instrument in writing signed by the party against whom enforcement is sought.
No such
amendment shall be effective to the extent that it applies to less than all
of
the holders of the applicable
Securities then outstanding. No consideration shall be offered or paid to any
Person to
amend
or consent to a waiver or modification of any provision of any of the
Transaction Documents
unless the same consideration also is offered to all of the parties to the
Transaction Documents,
holders of Notes. The Company has not, directly or indirectly, made any
agreements
with any Buyers relating to the terms or conditions of the transactions
contemplated by the Transaction Documents except as set forth in the Transaction
Documents.
(f) Notices.
Any
notices, consents, waivers or other communications required or permitted
to be given under the terms of this Agreement must be in writing and will be
deemed to
have
been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt,
when sent by
facsimile (provided confirmation of transmission is mechanically or
electronically generated and
kept
on file by the sending party); or (iii) one Business Day after deposit with
an
overnight courier service, in each case properly addressed to the party to
receive the same. The addresses and facsimile numbers for such communications
shall be:
If
to the
Company:
Mohen,
Inc. d/b/a Spiral Frog
00
Xxxxxx
Xxxxxx
Xxxxxx
Xx.
Xxx
Xxxx,
XX 00000
Attention: Chief
Executive Officer
With
a
copy to:
Gottbetter
& Partners, LLP
000
Xxxxxxx Xxxxxx, Xxx
Xxxx,
XX 00000
Attention: D.
Xxxxxx
Xxxxxxx, Esq.
Telephone: (000)
000-0000
Facsimile: (000)
000-0000
If
to a
Buyer, to its address and facsimile number set forth on the Schedule of Buyers,
with copies to such Buyer's representatives as set forth
on
the Schedule of Buyers
24
If
to the
Collateral Agent:
Gottbetter
Capital Finance, LLC
000
Xxxxxxx Xxxxxx 00xx
Xxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
Attention: Xxxxx
X.
Xxxxxxx
Telephone: (000)
000-0000
Facsimile: (000)
000-0000
or
to
such other address and/or facsimile number and/or to the attention of such
other
Person as the
recipient party has specified by written notice given to each other party five
(5) days prior to the
effectiveness of such change. Written confirmation of receipt (A) given by
the
recipient of such
notice, consent, waiver or other communication, (B) mechanically or
electronically generated
by the sender's facsimile machine containing the time, date, recipient facsimile
number and
an
image of the first page of such transmission or (C) provided by an overnight
courier service
shall be rebuttable evidence of personal service, receipt by facsimile or
receipt from an overnight courier service in accordance with clause (i), (ii)
or
(iii) above, respectively.
(g) Successors
and Assigns. This
Agreement shall be binding upon and inure to the benefit of the parties and
their respective successors and assigns, including any purchasers of the Notes.
The Company shall not assign this Agreement or any rights or obligations
hereunder without
the prior written consent of the Required Holders (unless the Company is in
compliance with
the
applicable provisions governing Fundamental Transactions set forth in the
Notes). A Buyer
may
assign some or all of its rights hereunder without the consent of the Company,
in which
event such assignee shall be deemed to be a Buyer hereunder with respect to
such
assigned
rights; provided that such assignee agrees in writing to be bound by all of
the
provisions contained
herein.
(h) No
Third Party Beneficiaries. This
Agreement is intended for the benefit of the parties
hereto and their respective permitted successors and assigns, and is not for
the
benefit of, nor
may
any provision hereof be enforced by, any other Person.
(i) Survival.
Unless
this Agreement is terminated under Section 8, (x) the representations
and warranties of the Buyers contained in Section 2, (y) the representations
and
warranties
of the Company contained in Section 3, and (z) the covenants and agreements
of
the parties contained in Sections 4 and 9 shall survive for so long as any
of
the Notes remain outstanding
or the original purchasers of the Notes beneficially own at least 5% of the
Common Stock
of
the Company, calculated in accordance with Section 13(d) of the 1934 Act and
Regulation 1 3D-G thereunder. Each Buyer shall be responsible for its own
representations, warranties, agreements and covenants hereunder.
(j) Further
Assurances. Each
party shall do and perform, or cause to be done and performed,
all such further acts and things, and shall execute and deliver all such other
agreements,
certificates, instruments and documents, as any other party may reasonably
request in
order
to carry out the intent and accomplish the purposes of this Agreement and the
consummation of the transactions contemplated hereby.
25
(k) Indemnification.
In
consideration of each Buyer’s execution and delivery of the Transaction
Documents and acquiring the Securities thereunder, and in addition to all of
the
Company’s
other obligations under the Transaction Documents, the Company shall defend,
protect, indemnify and hold harmless each Buyer and all of their stockholders,
partners, members,
officers, directors, employees and direct or indirect investors and any of
the
foregoing Person’s
agents or other representatives (including, without limitation, those retained
in connection with the transactions contemplated by this Agreement)
(collectively, the "Indemnitees")
from
and
against any and all actions, causes of action, suits, claims, losses, costs,
penalties, fees, liabilities and damages, and expenses in connection therewith,
and including
reasonable attorneys' fees and disbursements (the "Indemnified
Liabilities"), incurred
by
any
Indemnitee as a result of, or arising out of, or relating to (a) any
misrepresentation or breach
of
any representation or warranty made by the Company in the Transaction Documents
or any
other
certificate, instrument or document contemplated hereby or thereby, (b) any
breach of any covenant, agreement or obligation of the Company contained in
the
Transaction Documents or any other certificate, instrument or document
contemplated hereby or thereby or (c) any cause of
action, suit or claim brought or made against such Indemnitee by a third party
(including for these
purposes a derivative action brought on behalf of the Company) and arising
out
of or resulting
from (i) the execution, delivery, performance or enforcement of the Transaction
Documents
or any other certificate, instrument or document contemplated hereby or thereby,
(ii) any
transaction financed or to be financed in whole or in part, directly or
indirectly, with the proceeds
of the issuance of the Securities, or (iii) the status of such Buyer or holder
of the Securities
as an investor in the Company pursuant to the transactions contemplated by
the
Transaction
Documents. To the extent that the foregoing undertaking by the Company may
be
unenforceable
for any reason, the Company shall make the maximum contribution to the
payment
and satisfaction of each of the Indemnified Liabilities which is permissible
under applicable
law. Except as otherwise set forth herein, the mechanics and procedures with
respect to
the
rights and obligations under this Section 9(k) shall be the same as those set
forth in Section 6 of the Registration Rights Agreement.
(l) No
Strict Construction. The
language used in this Agreement will be deemed to be
the
language chosen by the parties to express their mutual intent, and no rules
of
strict construction will be applied against any party.
(m)
Remedies.
Each
Buyer and each holder of the Securities shall have all rights and remedies
set forth in the Transaction Documents and all rights and remedies which such
holders have
been
granted at any time under any other agreement or contract and all of the rights
which such holders have under any law. Any Person having any rights under any
provision of this Agreement shall be entitled to enforce such rights
specifically (without posting a bond or other security),
to recover damages by reason of any breach of any provision of this Agreement
and to exercise
all other rights granted by law. Furthermore, the Company recognizes that in
the
event that it fails to perform, observe, or discharge any or all of its
obligations under the Transaction Documents,
any remedy at law may prove to be inadequate relief to the Buyers. The Companyt
herefore agrees that the Buyers shall be entitled to seek temporary and
permanent injunctive relief
in
any such case without the necessity of proving actual damages and without
posting a bond
or
other security.
26
(n) Rescission
and Withdrawal Right. Notwithstanding
anything to the contrary contained
in (and without limiting any similar provisions of) the Transaction Documents,
whenever
any Buyer exercises a right, election, demand or option under a Transaction
Document and
the
Company does not timely perform its related obligations within the periods
therein provided,
then such Buyer may rescind or withdraw, in its sole discretion from time to
time upon written
notice to the Company, any relevant notice, demand or election in whole or
in
part without
prejudice to its future actions and rights.
(o) Payment
Set Aside. To
the
extent that the Company makes a payment or payments
to the Buyers hereunder or pursuant to any of the other Transaction Documents
or
the Buyers
enforce or exercise their rights hereunder or thereunder, and such payment
or
payments or
the
proceeds of such enforcement or exercise or any part thereof are subsequently
invalidated, declared
to be fraudulent or preferential, set aside, recovered from, disgorged by or
are
required to
be
refunded, repaid or otherwise restored to the Company, a trustee, receiver
or
any other Person
under any law (including, without limitation, any bankruptcy law, foreign,
state
or federal law,
common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied
shall be revived and continued in full force and effect as if such payment
had
not been made or such enforcement or setoff had not occurred.
(p) Independent
Nature of Buyers' Obligations and Rights. The
obligations of each Buyer
under any Transaction Document are several and not joint with the obligations
of
any other
Buyer, and no Buyer shall be responsible in any way for the performance of
the
obligations of
any
other Buyer under any Transaction Document. Nothing contained herein or in
any
other Transaction Document, and no action taken by any Buyer pursuant hereto
or
thereto, shall be deemed
to
constitute the Buyers as a partnership, an association, a joint venture or
any
other kind of
entity, or create a presumption that the Buyers are in any way acting in concert
or as a group with
respect to such obligations or the transactions contemplated by the Transaction
Documents and
the
Company acknowledges that to its knowledge the Buyers are not acting in concert
or as a group, and the Company will not assert any such claim, with respect
to
such obligations or the transactions contemplated by the Transaction Documents.
Each Buyer confirms that it has independently participated in the negotiation
of
the transaction contemplated hereby with the advice
of
its own counsel and advisors. Each Buyer shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights
arising out of this Agreement or out
of
any other Transaction Documents, and it shall not be necessary for any other
Buyer to be joined as an additional party in any proceeding for such
purpose.
(q) Litigation
Expenses. In
the
event of any judgment of a court or arbitration body on
any
dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein that is not appealed within thirty (30) days of
such
judgment, the prevailing party
in
such judgment may recover its reasonable expenses in obtaining such judgment
(including
without limitation amounts paid in settlement, interest, court costs, costs
of
investigators, fees and expenses of attorneys, accountants,
financial advisors and other experts, and
other
expenses of litigation), provided that if such prevailing party prevails on
several motions
in the judgment and does not prevail on others, it shall be in the discretion
of
a court or arbitration
body to determine what percentage of such reasonable expenses the prevailing
party is
entitled to receive.
[Signature
Page Follows]
27
IN
WITNESS WHEREOF, each
Buyer and the Company have caused their respective signature
page to this Purchase Agreement to be duly executed as of the date first written
above.
MOHEN, INC. | ||
|
|
|
By: | /s/ Xxxxxxx Xxxxxx | |
Xxxxxxx Xxxxxx |
||
Corporate Secretary |
28
IN
WITNESS WHEREOF, each
Buyer and the Company have caused their respective signature
page to this Purchase Agreement to be duly executed as of the date first written
above.
BUYERS:
_______________________________________
Name:
_______________________________________
Name:
_______________________________________
Name:
_______________________________________
Name:
29
SCHEDULE
OF BUYERS
(1)
|
(2)
|
(3)
|
(4)
|
Legal
Representative’s
|
|||
Address
and
|
Aggregate
|
Address
and
|
|
Buyer
|
Facsimile
Number
|
Purchase
Price
|
Facsimile
Number
|
Golden
Den Corp.
|
RDR
Group
|
50,000
|
|
0000
X. Xxxxxxx Xxxx
|
|||
Xxxxxxx,
XX 00000
|
30
EXHIBITS
Exhibit
A Form
of
Notes
Exhibit
B Registration
Rights Agreement
Exhibit
C Form
of
Security Agreement
Exhibit
D Form
of
Pledge Agreement
Exhibit
E Irrevocable
Transfer Agent Instructions
Exhibit
F Form
of
Resolutions, Articles of Incorporation and By-Laws
SCHEDULES
Schedule
3(a) Qualification
Schedule
3(b) Authorization,
Enforcement, Validity
Schedule
3(d) No
Conflicts
Schedule
3(e) Consents
Schedule
3(g) Consultant
Schedule
3(j) Financial
Statements
Schedule
3(k) Conduct
of Business; Regulatory Permits
Schedule
3(m) Transactions
with Affiliates
Schedule
3(n) Equity
Capitalization
Schedule
3(o) Indebtedness
and Other Contracts
Schedule
3(p) Absence
of Litigation
Schedule
3(r) Employee
Relations
Schedule
3(s) Title
Schedule
3(t) Intellectual
Property Rights
Schedule
3(w) Tax
Status
Schedule
3(x) Ranking
of Notes
Schedule
4(d) Use
of
Proceeds
Schedule
4(o) Additional
Issuances of Securities
Schedule
4(s) Transactions
with Affiliates